- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04310007
Testen van de toevoeging van de pil-chemotherapie, Cabozantinib, aan de standaard immuuntherapie Nivolumab in vergelijking met standaard chemotherapie voor niet-kleincellige longkanker
Een gerandomiseerde fase II-studie van cabozantinib en cabozantinib plus nivolumab versus standaardchemotherapie bij patiënten met eerder behandeld niet-plaveiselcel-NSCLC
This phase II trial compares cabozantinib alone and the combination of cabozantinib and nivolumab to standard chemotherapy in the treatment of patients with non-squamous non-small cell lung cancer (NSCLC). Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as docetaxel, gemcitabine hydrochloride, paclitaxel, and nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving cabozantinib alone or in combination with nivolumab may be more effective than standard chemotherapy in treating patients with non-small cell lung cancer.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
PRIMARY OBJECTIVE:
I. To determine whether cabozantinib alone, or the combination of nivolumab and cabozantinib, as compared to standard chemotherapy alone, extends progression-free survival (PFS) for this patient population with non squamous NSCLC.
SECONDARY OBJECTIVES:
I. To determine the overall survival for each arm of the trial. II. To evaluate the best overall radiographic response rate for each arm of the trial.
III. To evaluate and describe the toxicity profile of monotherapy with cabozantinib, and the combination of nivolumab and cabozantinib in this patient population with non-squamous NSCLC.
EXPLORATORY IMAGING OBJECTIVES:
I. To describe time point tumor response assessment, overall best response, progression-free survival and overall survival using the conventional Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria and the exploratory revised CHOI criteria with all measurements performed by the central review.
II. To compare the progression-free survival using the RECIST1.1 imaging response assessment measurements by site study personnel to those performed by central review.
EXPLORATORY CORRELATIVE OBJECTIVE:
I. To perform correlative biomarker research on tissue and blood biospecimens collected within this trial.
OUTLINE:
STEP 1: Patients are randomized to 1 of 3 arms.
ARM A: Patients receive cabozantinib S-malate orally (PO) once daily (QD). Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.
ARM B: Patients receive cabozantinib S-malate PO QD and nivolumab intravenously (IV) over 30 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.
ARM C: Patients receive ramucirumab IV over 30-60 minutes and docetaxel IV over 1 hour on day 1, or docetaxel IV over 1 hour on days 1 and 8, or gemcitabine hydrochloride IV on days 1 and 8, or paclitaxel IV over 3 hours on day 1, or nab-paclitaxel IV over 30 minutes on days 1 and 8. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity and at the discretion of the treating physician.
STEP 2: Patients in Arm C experiencing disease progression are assigned to Arm Z.
ARM Z: Patients receive cabozantinib S-malate PO QD and nivolumab IV over 30 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.
Patients in all arms undergo echocardiogram (ECHO) as clinically indicated, computed tomography (CT) throughout the trial, and collection of blood on study.
After the completion of study treatment, patients are followed up every 3 months for up to 3 years.
Studietype
Inschrijving (Geschat)
Fase
- Fase 2
Contacten en locaties
Studie Locaties
-
-
Alabama
-
Birmingham, Alabama, Verenigde Staten, 35233
- Veterans Administration Medical Center - Birmingham
-
-
Alaska
-
Anchorage, Alaska, Verenigde Staten, 98508
- Anchorage Associates in Radiation Medicine
-
Anchorage, Alaska, Verenigde Staten, 99508
- Alaska Breast Care and Surgery LLC
-
Anchorage, Alaska, Verenigde Staten, 99508
- Alaska Oncology and Hematology LLC
-
Anchorage, Alaska, Verenigde Staten, 99508
- Alaska Women's Cancer Care
-
Anchorage, Alaska, Verenigde Staten, 99508
- Anchorage Oncology Centre
-
Anchorage, Alaska, Verenigde Staten, 99508
- Katmai Oncology Group
-
Anchorage, Alaska, Verenigde Staten, 99508
- Providence Alaska Medical Center
-
Anchorage, Alaska, Verenigde Staten, 99504
- Anchorage Radiation Therapy Center
-
Fairbanks, Alaska, Verenigde Staten, 99701
- Fairbanks Memorial Hospital
-
-
Arizona
-
Goodyear, Arizona, Verenigde Staten, 85338
- CTCA at Western Regional Medical Center
-
Kingman, Arizona, Verenigde Staten, 86401
- Kingman Regional Medical Center
-
Phoenix, Arizona, Verenigde Staten, 85004
- Cancer Center at Saint Joseph's
-
Tucson, Arizona, Verenigde Staten, 85719
- Banner University Medical Center - Tucson
-
Tucson, Arizona, Verenigde Staten, 85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Fort Smith, Arkansas, Verenigde Staten, 72903
- Mercy Hospital Fort Smith
-
Hot Springs, Arkansas, Verenigde Staten, 71913
- CHI Saint Vincent Cancer Center Hot Springs
-
-
California
-
Arroyo Grande, California, Verenigde Staten, 93420
- PCR Oncology
-
Arroyo Grande, California, Verenigde Staten, 93420
- Mission Hope Medical Oncology - Arroyo Grande
-
Burbank, California, Verenigde Staten, 91505
- Providence Saint Joseph Medical Center/Disney Family Cancer Center
-
Carmichael, California, Verenigde Staten, 95608
- Mercy San Juan Medical Center
-
Carmichael, California, Verenigde Staten, 95608
- Mercy Cancer Center - Carmichael
-
Elk Grove, California, Verenigde Staten, 95758
- Mercy Cancer Center - Elk Grove
-
Fremont, California, Verenigde Staten, 94538
- Washington Health
-
Marysville, California, Verenigde Staten, 95901
- Fremont - Rideout Cancer Center
-
Orange, California, Verenigde Staten, 92868
- Saint Joseph Hospital - Orange
-
Palo Alto, California, Verenigde Staten, 94304
- Stanford Cancer Institute Palo Alto
-
Rocklin, California, Verenigde Staten, 95765
- Mercy Cancer Center - Rocklin
-
Sacramento, California, Verenigde Staten, 95817
- University of California Davis Comprehensive Cancer Center
-
Sacramento, California, Verenigde Staten, 95816
- Mercy Cancer Center - Sacramento
-
San Luis Obispo, California, Verenigde Staten, 93401
- Pacific Central Coast Health Center-San Luis Obispo
-
Santa Maria, California, Verenigde Staten, 93444
- Mission Hope Medical Oncology - Santa Maria
-
Woodland, California, Verenigde Staten, 95695
- Woodland Memorial Hospital
-
-
Colorado
-
Aurora, Colorado, Verenigde Staten, 80012
- Rocky Mountain Cancer Centers-Aurora
-
Aurora, Colorado, Verenigde Staten, 80012
- The Medical Center of Aurora
-
Boulder, Colorado, Verenigde Staten, 80303
- Boulder Community Foothills Hospital
-
Boulder, Colorado, Verenigde Staten, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Centennial, Colorado, Verenigde Staten, 80112
- Rocky Mountain Cancer Centers - Centennial
-
Colorado Springs, Colorado, Verenigde Staten, 80907
- Penrose-Saint Francis Healthcare
-
Colorado Springs, Colorado, Verenigde Staten, 80907
- Rocky Mountain Cancer Centers-Penrose
-
Colorado Springs, Colorado, Verenigde Staten, 80923
- Saint Francis Cancer Center
-
Denver, Colorado, Verenigde Staten, 80218
- Presbyterian - Saint Lukes Medical Center - Health One
-
Denver, Colorado, Verenigde Staten, 80220
- Rose Medical Center
-
Denver, Colorado, Verenigde Staten, 80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, Verenigde Staten, 80220
- Rocky Mountain Cancer Centers-Rose
-
Denver, Colorado, Verenigde Staten, 80218
- Colorado Blood Cancer Institute
-
Denver, Colorado, Verenigde Staten, 80204
- Cancer Center of Colorado at Sloan's Lake
-
Denver, Colorado, Verenigde Staten, 80209
- The Women's Imaging Center
-
Denver, Colorado, Verenigde Staten, 80206
- National Jewish Health-Main Campus
-
Denver, Colorado, Verenigde Staten, 80220
- Western Surgical Care
-
Denver, Colorado, Verenigde Staten, 80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Denver, Colorado, Verenigde Staten, 80210
- AdventHealth Porter
-
Durango, Colorado, Verenigde Staten, 81301
- Mercy Medical Center
-
Durango, Colorado, Verenigde Staten, 81301
- CommonSpirit Cancer Center Mercy
-
Englewood, Colorado, Verenigde Staten, 80113
- Mountain Blue Cancer Care Center - Swedish
-
Englewood, Colorado, Verenigde Staten, 80113
- Swedish Medical Center
-
Englewood, Colorado, Verenigde Staten, 80113
- Rocky Mountain Cancer Centers - Swedish
-
Englewood, Colorado, Verenigde Staten, 80113
- The Melanoma and Skin Cancer Institute
-
Fort Collins, Colorado, Verenigde Staten, 80524
- Poudre Valley Hospital
-
Fort Collins, Colorado, Verenigde Staten, 80528
- Cancer Care and Hematology-Fort Collins
-
Golden, Colorado, Verenigde Staten, 80401
- National Jewish Health-Western Hematology Oncology
-
Grand Junction, Colorado, Verenigde Staten, 81501
- Saint Mary's Hospital and Regional Medical Center
-
Greeley, Colorado, Verenigde Staten, 80631
- UCHealth Greeley Hospital
-
Greeley, Colorado, Verenigde Staten, 80631
- Banner North Colorado Medical Center
-
Highlands Ranch, Colorado, Verenigde Staten, 80129
- UCHealth Highlands Ranch Hospital
-
Lafayette, Colorado, Verenigde Staten, 80026
- Good Samaritan Hospital - Cancer Centers of Colorado
-
Lakewood, Colorado, Verenigde Staten, 80228
- Rocky Mountain Cancer Centers-Lakewood
-
Lakewood, Colorado, Verenigde Staten, 80228
- CommonSpirit Saint Anthony Hospital Cancer Center
-
Littleton, Colorado, Verenigde Staten, 80120
- Rocky Mountain Cancer Centers-Littleton
-
Littleton, Colorado, Verenigde Staten, 80122
- AdventHealth Littleton
-
Lone Tree, Colorado, Verenigde Staten, 80124
- Sky Ridge Medical Center
-
Lone Tree, Colorado, Verenigde Staten, 80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Longmont, Colorado, Verenigde Staten, 80501
- Longmont United Hospital
-
Longmont, Colorado, Verenigde Staten, 80501
- Rocky Mountain Cancer Centers-Longmont
-
Loveland, Colorado, Verenigde Staten, 80538
- Medical Center of the Rockies
-
Loveland, Colorado, Verenigde Staten, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
Parker, Colorado, Verenigde Staten, 80138
- AdventHealth Parker
-
Pueblo, Colorado, Verenigde Staten, 81004
- Saint Mary Corwin Medical Center
-
Thornton, Colorado, Verenigde Staten, 80260
- Rocky Mountain Cancer Centers-Thornton
-
Thornton, Colorado, Verenigde Staten, 80260
- National Jewish Health-Northern Hematology Oncology
-
-
Connecticut
-
West Haven, Connecticut, Verenigde Staten, 06516
- Veterans Affairs Connecticut Healthcare System-West Haven Campus
-
-
Florida
-
Aventura, Florida, Verenigde Staten, 33180
- Mount Sinai Comprehensive Cancer Center at Aventura
-
Fort Lauderdale, Florida, Verenigde Staten, 33308
- Holy Cross Hospital
-
Miami Beach, Florida, Verenigde Staten, 33140
- Mount Sinai Medical Center
-
-
Georgia
-
Atlanta, Georgia, Verenigde Staten, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, Verenigde Staten, 30322
- Emory University Hospital/Winship Cancer Institute
-
Savannah, Georgia, Verenigde Staten, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
-
Idaho
-
Boise, Idaho, Verenigde Staten, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, Verenigde Staten, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, Verenigde Staten, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene, Idaho, Verenigde Staten, 83814
- Kootenai Health - Coeur d'Alene
-
Emmett, Idaho, Verenigde Staten, 83617
- Walter Knox Memorial Hospital
-
Fruitland, Idaho, Verenigde Staten, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Verenigde Staten, 83642
- Idaho Urologic Institute-Meridian
-
Meridian, Idaho, Verenigde Staten, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Verenigde Staten, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa, Idaho, Verenigde Staten, 83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, Verenigde Staten, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, Verenigde Staten, 83864
- Kootenai Clinic Cancer Services - Sandpoint
-
Twin Falls, Idaho, Verenigde Staten, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Alton, Illinois, Verenigde Staten, 62002
- OSF Saint Anthony's Health Center
-
Aurora, Illinois, Verenigde Staten, 60504
- Rush-Copley Medical Center
-
Barrington, Illinois, Verenigde Staten, 60010
- Advocate Good Shepherd Hospital
-
Bloomington, Illinois, Verenigde Staten, 61704
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Verenigde Staten, 61520
- Illinois CancerCare-Canton
-
Carbondale, Illinois, Verenigde Staten, 62902
- Memorial Hospital of Carbondale
-
Carterville, Illinois, Verenigde Staten, 62918
- SIH Cancer Institute
-
Carthage, Illinois, Verenigde Staten, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Verenigde Staten, 62801
- Centralia Oncology Clinic
-
Centralia, Illinois, Verenigde Staten, 62801
- Saint Mary's Hospital
-
Chicago, Illinois, Verenigde Staten, 60612
- University of Illinois
-
Chicago, Illinois, Verenigde Staten, 60657
- Advocate Illinois Masonic Medical Center
-
Crystal Lake, Illinois, Verenigde Staten, 60014
- AMG Crystal Lake - Oncology
-
Danville, Illinois, Verenigde Staten, 61832
- Carle at The Riverfront
-
Decatur, Illinois, Verenigde Staten, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Verenigde Staten, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Dixon, Illinois, Verenigde Staten, 61021
- Illinois CancerCare-Dixon
-
Downers Grove, Illinois, Verenigde Staten, 60515
- Advocate Good Samaritan Hospital
-
Effingham, Illinois, Verenigde Staten, 62401
- Crossroads Cancer Center
-
Effingham, Illinois, Verenigde Staten, 62401
- Carle Physician Group-Effingham
-
Elgin, Illinois, Verenigde Staten, 60123
- Advocate Sherman Hospital
-
Eureka, Illinois, Verenigde Staten, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, Verenigde Staten, 61401
- Western Illinois Cancer Treatment Center
-
Galesburg, Illinois, Verenigde Staten, 61401
- Illinois CancerCare-Galesburg
-
Hazel Crest, Illinois, Verenigde Staten, 60429
- Advocate South Suburban Hospital
-
Hines, Illinois, Verenigde Staten, 60141
- Edward Hines Jr VA Hospital
-
Kewanee, Illinois, Verenigde Staten, 61443
- Illinois CancerCare-Kewanee Clinic
-
Libertyville, Illinois, Verenigde Staten, 60048
- Condell Memorial Hospital
-
Libertyville, Illinois, Verenigde Staten, 60048
- AMG Libertyville - Oncology
-
Macomb, Illinois, Verenigde Staten, 61455
- Illinois CancerCare-Macomb
-
Mattoon, Illinois, Verenigde Staten, 61938
- Carle Physician Group-Mattoon/Charleston
-
Mount Vernon, Illinois, Verenigde Staten, 62864
- SSM Health Good Samaritan
-
O'Fallon, Illinois, Verenigde Staten, 62269
- Cancer Care Center of O'Fallon
-
Oak Lawn, Illinois, Verenigde Staten, 60453-2699
- Advocate Christ Medical Center
-
Ottawa, Illinois, Verenigde Staten, 61350
- Illinois CancerCare-Ottawa Clinic
-
Park Ridge, Illinois, Verenigde Staten, 60068
- Advocate Lutheran General Hospital
-
Pekin, Illinois, Verenigde Staten, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Verenigde Staten, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Verenigde Staten, 61615
- Illinois CancerCare-Peoria
-
Peru, Illinois, Verenigde Staten, 61354
- Illinois CancerCare-Peru
-
Peru, Illinois, Verenigde Staten, 61354
- Valley Radiation Oncology
-
Princeton, Illinois, Verenigde Staten, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, Verenigde Staten, 61114
- UW Health Carbone Cancer Center Rockford
-
Springfield, Illinois, Verenigde Staten, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Verenigde Staten, 62702
- Springfield Clinic
-
Springfield, Illinois, Verenigde Staten, 62781
- Springfield Memorial Hospital
-
Swansea, Illinois, Verenigde Staten, 62226
- Southwest Illinois Health Services LLP
-
Urbana, Illinois, Verenigde Staten, 61801
- Carle Cancer Center
-
Urbana, Illinois, Verenigde Staten, 61801
- The Carle Foundation Hospital
-
Washington, Illinois, Verenigde Staten, 61571
- Illinois CancerCare - Washington
-
Yorkville, Illinois, Verenigde Staten, 60560
- Rush-Copley Healthcare Center
-
-
Indiana
-
Richmond, Indiana, Verenigde Staten, 47374
- Reid Health
-
South Bend, Indiana, Verenigde Staten, 46601
- Memorial Hospital of South Bend
-
-
Iowa
-
Ames, Iowa, Verenigde Staten, 50010
- Mary Greeley Medical Center
-
Ames, Iowa, Verenigde Staten, 50010
- McFarland Clinic - Ames
-
Bettendorf, Iowa, Verenigde Staten, 52722
- University of Iowa Healthcare Cancer Services Quad Cities
-
Boone, Iowa, Verenigde Staten, 50036
- McFarland Clinic - Boone
-
Carroll, Iowa, Verenigde Staten, 51401
- Saint Anthony Regional Hospital
-
Clive, Iowa, Verenigde Staten, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Verenigde Staten, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Council Bluffs, Iowa, Verenigde Staten, 51503
- Alegent Health Mercy Hospital
-
Council Bluffs, Iowa, Verenigde Staten, 51503
- Heartland Oncology and Hematology LLP
-
Council Bluffs, Iowa, Verenigde Staten, 51503
- Methodist Jennie Edmundson Hospital
-
Creston, Iowa, Verenigde Staten, 50801
- Greater Regional Medical Center
-
Des Moines, Iowa, Verenigde Staten, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Verenigde Staten, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Verenigde Staten, 50314
- Broadlawns Medical Center
-
Des Moines, Iowa, Verenigde Staten, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Verenigde Staten, 50309
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Des Moines, Iowa, Verenigde Staten, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
Fort Dodge, Iowa, Verenigde Staten, 50501
- McFarland Clinic - Trinity Cancer Center
-
Fort Dodge, Iowa, Verenigde Staten, 50501
- UI Healthcare Mission Cancer and Blood - Fort Dodge
-
Iowa City, Iowa, Verenigde Staten, 52242
- University of Iowa/Holden Comprehensive Cancer Center
-
Jefferson, Iowa, Verenigde Staten, 50129
- McFarland Clinic - Jefferson
-
Marshalltown, Iowa, Verenigde Staten, 50158
- McFarland Clinic - Marshalltown
-
West Des Moines, Iowa, Verenigde Staten, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, Verenigde Staten, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Garden City, Kansas, Verenigde Staten, 67846
- Central Care Cancer Center - Garden City
-
Great Bend, Kansas, Verenigde Staten, 67530
- Central Care Cancer Center - Great Bend
-
Hays, Kansas, Verenigde Staten, 67601
- HaysMed
-
Lawrence, Kansas, Verenigde Staten, 66044
- Lawrence Memorial Hospital
-
Olathe, Kansas, Verenigde Staten, 66061
- The University of Kansas Cancer Center - Olathe
-
Overland Park, Kansas, Verenigde Staten, 66213
- Saint Luke's South Hospital
-
Pittsburg, Kansas, Verenigde Staten, 66762
- Freeman Physician Group of Pittsburg
-
Pittsburg, Kansas, Verenigde Staten, 66762
- Mercy Hospital Pittsburg
-
Salina, Kansas, Verenigde Staten, 67401
- Salina Regional Health Center
-
Topeka, Kansas, Verenigde Staten, 66606
- University of Kansas Health System Saint Francis Campus
-
-
Kentucky
-
Bardstown, Kentucky, Verenigde Staten, 40004
- CommonSpirit Saint Joseph Hospital - Bardstown
-
Corbin, Kentucky, Verenigde Staten, 40701
- Commonwealth Cancer Center-Corbin
-
Lexington, Kentucky, Verenigde Staten, 40504
- Saint Joseph Radiation Oncology Resource Center
-
Lexington, Kentucky, Verenigde Staten, 40509
- CommonSpirit Saint Joseph Medical Center - East Lexington
-
Lexington, Kentucky, Verenigde Staten, 40504
- CommonSpirit Saint Joseph Hospital - Lexington
-
London, Kentucky, Verenigde Staten, 40741
- CommonSpirit Saint Joseph Hospital London
-
Louisville, Kentucky, Verenigde Staten, 40202
- Jewish Hospital
-
Louisville, Kentucky, Verenigde Staten, 40245
- UofL Health Medical Center Northeast
-
Louisville, Kentucky, Verenigde Staten, 40215
- Saints Mary and Elizabeth Hospital
-
Mount Sterling, Kentucky, Verenigde Staten, 40353
- CommonSpirit Saint Joseph Hospital Mount Sterling
-
Owensboro, Kentucky, Verenigde Staten, 42303
- Owensboro Health Mitchell Memorial Cancer Center
-
Paducah, Kentucky, Verenigde Staten, 42003
- Mercy Health - Paducah Cancer Center
-
Shepherdsville, Kentucky, Verenigde Staten, 40165
- Jewish Hospital Medical Center South
-
-
Louisiana
-
Baton Rouge, Louisiana, Verenigde Staten, 70805
- LSU Health Baton Rouge-North Clinic
-
Baton Rouge, Louisiana, Verenigde Staten, 70809
- Louisiana Hematology Oncology Associates LLC
-
Baton Rouge, Louisiana, Verenigde Staten, 70809
- Mary Bird Perkins Cancer Center
-
Baton Rouge, Louisiana, Verenigde Staten, 70808
- Our Lady of The Lake
-
Baton Rouge, Louisiana, Verenigde Staten, 70808
- Our Lady of the Lake Physician Group
-
Covington, Louisiana, Verenigde Staten, 70433
- Northshore Oncology Associates-Covington
-
Houma, Louisiana, Verenigde Staten, 70360
- Terrebonne General Medical Center
-
-
Maine
-
Augusta, Maine, Verenigde Staten, 04330
- Harold Alfond Center for Cancer Care
-
Biddeford, Maine, Verenigde Staten, 04005
- MaineHealth Maine Medical Center - Biddeford
-
Sanford, Maine, Verenigde Staten, 04073
- MaineHealth Cancer Care and IV Therapy - Sanford
-
South Portland, Maine, Verenigde Staten, 04106
- MaineHealth Cancer Care and IV Therapy - South Portland
-
-
Maryland
-
Baltimore, Maryland, Verenigde Staten, 21229
- Saint Agnes Hospital
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02118
- Boston Medical Center
-
Worcester, Massachusetts, Verenigde Staten, 01655
- UMass Memorial Medical Center - University Campus
-
-
Michigan
-
Adrian, Michigan, Verenigde Staten, 49221
- Hickman Cancer Center
-
Ann Arbor, Michigan, Verenigde Staten, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Battle Creek, Michigan, Verenigde Staten, 49017
- Bronson Battle Creek
-
Brighton, Michigan, Verenigde Staten, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Brighton, Michigan, Verenigde Staten, 48114
- Trinity Health Medical Center - Brighton
-
Canton, Michigan, Verenigde Staten, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Canton, Michigan, Verenigde Staten, 48188
- Trinity Health Medical Center - Canton
-
Caro, Michigan, Verenigde Staten, 48723
- Caro Cancer Center
-
Chelsea, Michigan, Verenigde Staten, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Chelsea, Michigan, Verenigde Staten, 48118
- Chelsea Hospital
-
Clarkston, Michigan, Verenigde Staten, 48346
- Hematology Oncology Consultants-Clarkston
-
Clarkston, Michigan, Verenigde Staten, 48346
- Newland Medical Associates-Clarkston
-
Detroit, Michigan, Verenigde Staten, 48236
- Henry Ford Health Saint John Hospital
-
East China Township, Michigan, Verenigde Staten, 48054
- Henry Ford River District Hospital
-
Flint, Michigan, Verenigde Staten, 48503
- Hurley Medical Center
-
Flint, Michigan, Verenigde Staten, 48503
- Genesee Hematology Oncology PC
-
Flint, Michigan, Verenigde Staten, 48503
- Genesys Hurley Cancer Institute
-
Flint, Michigan, Verenigde Staten, 48503
- Cancer Hematology Centers - Flint
-
Grand Rapids, Michigan, Verenigde Staten, 49503
- Trinity Health Grand Rapids Hospital
-
Grand Rapids, Michigan, Verenigde Staten, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Grand Rapids, Michigan, Verenigde Staten, 49503
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
-
Grosse Pointe Woods, Michigan, Verenigde Staten, 48236
- Henry Ford Saint John Hospital - Academic
-
Grosse Pointe Woods, Michigan, Verenigde Staten, 48236
- Henry Ford Saint John Hospital - Breast
-
Grosse Pointe Woods, Michigan, Verenigde Staten, 48236
- Henry Ford Saint John Hospital - Van Elslander
-
Kalamazoo, Michigan, Verenigde Staten, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Verenigde Staten, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Verenigde Staten, 49009
- Beacon Kalamazoo Cancer Center
-
Kalamazoo, Michigan, Verenigde Staten, 49048
- Beacon Kalamazoo
-
Lansing, Michigan, Verenigde Staten, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, Verenigde Staten, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Livonia, Michigan, Verenigde Staten, 48154
- Hope Cancer Clinic
-
Macomb, Michigan, Verenigde Staten, 48044
- Henry Ford Warren Hospital - Breast Macomb
-
Macomb, Michigan, Verenigde Staten, 48044
- Henry Ford Saint John Hospital - Macomb Medical
-
Marlette, Michigan, Verenigde Staten, 48453
- Saint Mary's Oncology/Hematology Associates of Marlette
-
Monroe, Michigan, Verenigde Staten, 48162
- Toledo Clinic Cancer Centers-Monroe
-
Muskegon, Michigan, Verenigde Staten, 49444
- Trinity Health Muskegon Hospital
-
Niles, Michigan, Verenigde Staten, 49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Norton Shores, Michigan, Verenigde Staten, 49444
- Cancer and Hematology Centers of Western Michigan - Norton Shores
-
Novi, Michigan, Verenigde Staten, 48374
- Henry Ford Health Providence Novi Hospital
-
Pontiac, Michigan, Verenigde Staten, 48341
- Hope Cancer Center
-
Pontiac, Michigan, Verenigde Staten, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Pontiac, Michigan, Verenigde Staten, 48341
- Michigan Healthcare Professionals Pontiac
-
Pontiac, Michigan, Verenigde Staten, 48341
- Trinity Health IHA Medical Group-Alice Gustafson Center
-
Reed City, Michigan, Verenigde Staten, 49677
- Corewell Health Reed City Hospital
-
Rochester Hills, Michigan, Verenigde Staten, 48309
- Henry Ford Rochester Hospital
-
Saginaw, Michigan, Verenigde Staten, 48604
- Oncology Hematology Associates of Saginaw Valley PC
-
Saginaw, Michigan, Verenigde Staten, 48601
- MyMichigan Medical Center Saginaw
-
Saint Joseph, Michigan, Verenigde Staten, 49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph, Michigan, Verenigde Staten, 49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Southfield, Michigan, Verenigde Staten, 48075
- Henry Ford Health Providence Southfield Hospital
-
Sterling Heights, Michigan, Verenigde Staten, 48312
- Bhadresh Nayak MD PC-Sterling Heights
-
Tawas City, Michigan, Verenigde Staten, 48764
- MyMichigan Medical Center Tawas
-
Traverse City, Michigan, Verenigde Staten, 49684
- Munson Medical Center
-
Warren, Michigan, Verenigde Staten, 48088
- Advanced Breast Care Center PLLC
-
Warren, Michigan, Verenigde Staten, 48093
- Macomb Hematology Oncology PC
-
Warren, Michigan, Verenigde Staten, 48093
- Henry Ford Madison Heights Hospital - Breast
-
Warren, Michigan, Verenigde Staten, 48093
- Henry Ford Health Warren Hospital
-
Warren, Michigan, Verenigde Staten, 48093
- Henry Ford Warren Hospital - GLCMS
-
West Branch, Michigan, Verenigde Staten, 48661
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Wyoming, Michigan, Verenigde Staten, 49519
- University of Michigan Health - West
-
Ypsilanti, Michigan, Verenigde Staten, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
Ypsilanti, Michigan, Verenigde Staten, 48106
- Huron Gastroenterology PC
-
-
Minnesota
-
Aitkin, Minnesota, Verenigde Staten, 56431
- Riverwood Healthcare Center
-
Baxter, Minnesota, Verenigde Staten, 56425
- Essentia Health - Baxter Clinic
-
Brainerd, Minnesota, Verenigde Staten, 56401
- Essentia Health Saint Joseph's Medical Center
-
Burnsville, Minnesota, Verenigde Staten, 55337
- Fairview Ridges Hospital
-
Burnsville, Minnesota, Verenigde Staten, 55337
- Minnesota Oncology - Burnsville
-
Cambridge, Minnesota, Verenigde Staten, 55008
- Cambridge Medical Center
-
Coon Rapids, Minnesota, Verenigde Staten, 55433
- Mercy Hospital
-
Deer River, Minnesota, Verenigde Staten, 56636
- Essentia Health - Deer River Clinic
-
Detroit Lakes, Minnesota, Verenigde Staten, 56501
- Essentia Health Saint Mary's - Detroit Lakes Clinic
-
Duluth, Minnesota, Verenigde Staten, 55805
- Essentia Health Cancer Center
-
Duluth, Minnesota, Verenigde Staten, 55805
- Essentia Health Saint Mary's Medical Center
-
Duluth, Minnesota, Verenigde Staten, 55805
- Miller-Dwan Hospital
-
Edina, Minnesota, Verenigde Staten, 55435
- Fairview Southdale Hospital
-
Ely, Minnesota, Verenigde Staten, 55731
- Essentia Health - Ely Clinic
-
Fergus Falls, Minnesota, Verenigde Staten, 56537
- Lake Region Healthcare Corporation-Cancer Care
-
Fosston, Minnesota, Verenigde Staten, 56542
- Essentia Health - Fosston
-
Fridley, Minnesota, Verenigde Staten, 55432
- Unity Hospital
-
Hibbing, Minnesota, Verenigde Staten, 55746
- Essentia Health Hibbing Clinic
-
International Falls, Minnesota, Verenigde Staten, 56649
- Essentia Health - International Falls Clinic
-
Maple Grove, Minnesota, Verenigde Staten, 55369
- Fairview Clinics and Surgery Center Maple Grove
-
Maplewood, Minnesota, Verenigde Staten, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Verenigde Staten, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Verenigde Staten, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Verenigde Staten, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, Verenigde Staten, 55454
- Health Partners Inc
-
Monticello, Minnesota, Verenigde Staten, 55362
- Monticello Cancer Center
-
Moose Lake, Minnesota, Verenigde Staten, 55767
- Essentia Health - Moose Lake Clinic
-
New Ulm, Minnesota, Verenigde Staten, 56073
- New Ulm Medical Center
-
Park Rapids, Minnesota, Verenigde Staten, 56470
- Essentia Health - Park Rapids
-
Princeton, Minnesota, Verenigde Staten, 55371
- Fairview Northland Medical Center
-
Robbinsdale, Minnesota, Verenigde Staten, 55422
- North Memorial Medical Health Center
-
Saint Louis Park, Minnesota, Verenigde Staten, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, Verenigde Staten, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Verenigde Staten, 55102
- United Hospital
-
Sandstone, Minnesota, Verenigde Staten, 55072
- Essentia Health Sandstone
-
Shakopee, Minnesota, Verenigde Staten, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Verenigde Staten, 55082
- Lakeview Hospital
-
Virginia, Minnesota, Verenigde Staten, 55792
- Essentia Health Virginia Clinic
-
Waconia, Minnesota, Verenigde Staten, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Verenigde Staten, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Verenigde Staten, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
Wyoming, Minnesota, Verenigde Staten, 55092
- Fairview Lakes Medical Center
-
-
Missouri
-
Ballwin, Missouri, Verenigde Staten, 63011
- Mercy Oncology and Hematology - Clayton-Clarkson
-
Bolivar, Missouri, Verenigde Staten, 65613
- Central Care Cancer Center - Bolivar
-
Branson, Missouri, Verenigde Staten, 65616
- Cox Cancer Center Branson
-
Cape Girardeau, Missouri, Verenigde Staten, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, Verenigde Staten, 63703
- Mercy Cancer Center - Cape Girardeau
-
City of Saint Peters, Missouri, Verenigde Staten, 63376
- Siteman Cancer Center at Saint Peters Hospital
-
Columbia, Missouri, Verenigde Staten, 65212
- MU Health - University Hospital/Ellis Fischel Cancer Center
-
Creve Coeur, Missouri, Verenigde Staten, 63141
- Siteman Cancer Center at West County Hospital
-
Farmington, Missouri, Verenigde Staten, 63640
- Parkland Health Center - Farmington
-
Jefferson City, Missouri, Verenigde Staten, 65109
- MU Health Care Goldschmidt Cancer Center
-
Joplin, Missouri, Verenigde Staten, 64804
- Freeman Health System
-
Joplin, Missouri, Verenigde Staten, 64804
- Mercy Hospital Joplin
-
Kansas City, Missouri, Verenigde Staten, 64111
- Saint Luke's Hospital of Kansas City
-
Kansas City, Missouri, Verenigde Staten, 64108
- University Health Truman Medical Center
-
Lee's Summit, Missouri, Verenigde Staten, 64086
- Saint Luke's East - Lee's Summit
-
Rolla, Missouri, Verenigde Staten, 65401
- Mercy Clinic-Rolla-Cancer and Hematology
-
Rolla, Missouri, Verenigde Staten, 65401
- Phelps Health Delbert Day Cancer Institute
-
Saint Joseph, Missouri, Verenigde Staten, 64506
- Heartland Regional Medical Center
-
Sainte Genevieve, Missouri, Verenigde Staten, 63670
- Sainte Genevieve County Memorial Hospital
-
Springfield, Missouri, Verenigde Staten, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Verenigde Staten, 65804
- Mercy Hospital Springfield
-
St Louis, Missouri, Verenigde Staten, 63110
- Washington University School of Medicine
-
St Louis, Missouri, Verenigde Staten, 63129
- Siteman Cancer Center-South County
-
St Louis, Missouri, Verenigde Staten, 63136
- Siteman Cancer Center at Christian Hospital
-
St Louis, Missouri, Verenigde Staten, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Verenigde Staten, 63109
- Mercy Infusion Center - Chippewa
-
St Louis, Missouri, Verenigde Staten, 63141
- Mercy Hospital Saint Louis
-
St Louis, Missouri, Verenigde Staten, 63128
- Mercy Hospital South
-
Sullivan, Missouri, Verenigde Staten, 63080
- Missouri Baptist Sullivan Hospital
-
Washington, Missouri, Verenigde Staten, 63090
- Mercy Hospital Washington
-
-
Montana
-
Anaconda, Montana, Verenigde Staten, 59711
- Community Hospital of Anaconda
-
Billings, Montana, Verenigde Staten, 59101
- Billings Clinic Cancer Center
-
Billings, Montana, Verenigde Staten, 59101
- Saint Vincent Healthcare
-
Billings, Montana, Verenigde Staten, 59102
- Saint Vincent Frontier Cancer Center
-
Bozeman, Montana, Verenigde Staten, 59715
- Bozeman Health Deaconess Hospital
-
Great Falls, Montana, Verenigde Staten, 59405
- Great Falls Clinic
-
Great Falls, Montana, Verenigde Staten, 59405
- Benefis Sletten Cancer Institute
-
Kalispell, Montana, Verenigde Staten, 59901
- Logan Health Medical Center
-
Missoula, Montana, Verenigde Staten, 59802
- Saint Patrick Hospital - Community Hospital
-
Missoula, Montana, Verenigde Staten, 59804
- Community Medical Center
-
-
Nebraska
-
Bellevue, Nebraska, Verenigde Staten, 68123
- Nebraska Medicine-Bellevue
-
Grand Island, Nebraska, Verenigde Staten, 68803
- Nebraska Cancer Specialists/Oncology Hematology West PC
-
Kearney, Nebraska, Verenigde Staten, 68847
- CHI Health Good Samaritan
-
Lincoln, Nebraska, Verenigde Staten, 68510
- Saint Elizabeth Regional Medical Center
-
Omaha, Nebraska, Verenigde Staten, 68114
- Nebraska Methodist Hospital
-
Omaha, Nebraska, Verenigde Staten, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, Verenigde Staten, 68124
- Alegent Health Bergan Mercy Medical Center
-
Omaha, Nebraska, Verenigde Staten, 68118
- Nebraska Medicine-Village Pointe
-
Omaha, Nebraska, Verenigde Staten, 68122
- Alegent Health Immanuel Medical Center
-
Omaha, Nebraska, Verenigde Staten, 68130
- Alegent Health Lakeside Hospital
-
Omaha, Nebraska, Verenigde Staten, 68114
- Oncology Associates PC
-
Omaha, Nebraska, Verenigde Staten, 68114
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
-
Papillion, Nebraska, Verenigde Staten, 68046
- Midlands Community Hospital
-
-
Nevada
-
Carson City, Nevada, Verenigde Staten, 89703
- Carson Tahoe Regional Medical Center
-
Henderson, Nevada, Verenigde Staten, 89052
- Comprehensive Cancer Centers of Nevada - Henderson
-
Henderson, Nevada, Verenigde Staten, 89052
- Cancer and Blood Specialists-Henderson
-
Henderson, Nevada, Verenigde Staten, 89052
- Las Vegas Cancer Center-Henderson
-
Henderson, Nevada, Verenigde Staten, 89074
- Comprehensive Cancer Centers of Nevada-Southeast Henderson
-
Henderson, Nevada, Verenigde Staten, 89052
- Comprehensive Cancer Centers of Nevada-Horizon Ridge
-
Henderson, Nevada, Verenigde Staten, 89074
- Las Vegas Urology - Green Valley
-
Henderson, Nevada, Verenigde Staten, 89074
- Las Vegas Urology - Pebble
-
Henderson, Nevada, Verenigde Staten, 89074
- Urology Specialists of Nevada - Green Valley
-
Henderson, Nevada, Verenigde Staten, 89074
- Oncology Las Vegas - Henderson
-
Las Vegas, Nevada, Verenigde Staten, 89144
- Summerlin Hospital Medical Center
-
Las Vegas, Nevada, Verenigde Staten, 89109
- Sunrise Hospital and Medical Center
-
Las Vegas, Nevada, Verenigde Staten, 89102
- OptumCare Cancer Care at Charleston
-
Las Vegas, Nevada, Verenigde Staten, 89106
- Radiation Oncology Centers of Nevada Central
-
Las Vegas, Nevada, Verenigde Staten, 89119
- Radiation Oncology Centers of Nevada Southeast
-
Las Vegas, Nevada, Verenigde Staten, 89128
- Comprehensive Cancer Centers of Nevada - Northwest
-
Las Vegas, Nevada, Verenigde Staten, 89128
- OptumCare Cancer Care at MountainView
-
Las Vegas, Nevada, Verenigde Staten, 89135
- Alliance for Childhood Diseases/Cure 4 the Kids Foundation
-
Las Vegas, Nevada, Verenigde Staten, 89144
- Comprehensive Cancer Centers of Nevada - Town Center
-
Las Vegas, Nevada, Verenigde Staten, 89144
- Comprehensive Cancer Centers of Nevada-Summerlin
-
Las Vegas, Nevada, Verenigde Staten, 89148
- Comprehensive Cancer Centers of Nevada
-
Las Vegas, Nevada, Verenigde Staten, 89169
- Comprehensive Cancer Centers of Nevada - Central Valley
-
Las Vegas, Nevada, Verenigde Staten, 89102
- University Medical Center of Southern Nevada
-
Las Vegas, Nevada, Verenigde Staten, 89106
- Cancer and Blood Specialists-Shadow
-
Las Vegas, Nevada, Verenigde Staten, 89109
- HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
-
Las Vegas, Nevada, Verenigde Staten, 89113
- HealthCare Partners Medical Group Oncology/Hematology-San Martin
-
Las Vegas, Nevada, Verenigde Staten, 89128
- Cancer and Blood Specialists-Tenaya
-
Las Vegas, Nevada, Verenigde Staten, 89128
- HealthCare Partners Medical Group Oncology/Hematology-Tenaya
-
Las Vegas, Nevada, Verenigde Staten, 89148-2405
- Las Vegas Cancer Center-Medical Center
-
Las Vegas, Nevada, Verenigde Staten, 89149
- HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
-
Las Vegas, Nevada, Verenigde Staten, 89128
- Ann M Wierman MD LTD
-
Las Vegas, Nevada, Verenigde Staten, 89074
- Las Vegas Urology - Pecos
-
Las Vegas, Nevada, Verenigde Staten, 89102
- Desert West Surgery
-
Las Vegas, Nevada, Verenigde Staten, 89103
- Hope Cancer Care of Nevada
-
Las Vegas, Nevada, Verenigde Staten, 89106
- Urology Specialists of Nevada - Central
-
Las Vegas, Nevada, Verenigde Staten, 89113
- Las Vegas Prostate Cancer Center
-
Las Vegas, Nevada, Verenigde Staten, 89113
- Las Vegas Urology - Sunset
-
Las Vegas, Nevada, Verenigde Staten, 89128
- Las Vegas Urology - Cathedral Rock
-
Las Vegas, Nevada, Verenigde Staten, 89128
- Las Vegas Urology - Smoke Ranch
-
Las Vegas, Nevada, Verenigde Staten, 89128
- Urology Specialists of Nevada - Northwest
-
Las Vegas, Nevada, Verenigde Staten, 89169
- University Cancer Center
-
Las Vegas, Nevada, Verenigde Staten, 89113
- Urology Specialists of Nevada - Southwest
-
Las Vegas, Nevada, Verenigde Staten, 89128
- Oncology Las Vegas - Tenaya
-
Las Vegas, Nevada, Verenigde Staten, 89183
- OptumCare Cancer Care at Fort Apache
-
Pahrump, Nevada, Verenigde Staten, 89048
- Hope Cancer Care of Nevada-Pahrump
-
Reno, Nevada, Verenigde Staten, 89502
- Renown Regional Medical Center
-
Reno, Nevada, Verenigde Staten, 89503
- Saint Mary's Regional Medical Center
-
Reno, Nevada, Verenigde Staten, 89509
- Radiation Oncology Associates
-
-
New Hampshire
-
Concord, New Hampshire, Verenigde Staten, 03301
- New Hampshire Oncology Hematology PA-Concord
-
Manchester, New Hampshire, Verenigde Staten, 03103
- Solinsky Center for Cancer Care
-
Manchester, New Hampshire, Verenigde Staten, 03103
- Elliot Hospital
-
-
New Jersey
-
Moorestown, New Jersey, Verenigde Staten, 08057
- Virtua Samson Cancer Center
-
Mount Holly, New Jersey, Verenigde Staten, 08060
- Virtua Memorial
-
Voorhees Township, New Jersey, Verenigde Staten, 08043
- Virtua Voorhees
-
-
New Mexico
-
Albuquerque, New Mexico, Verenigde Staten, 87106
- University of New Mexico Cancer Center
-
-
New York
-
Glens Falls, New York, Verenigde Staten, 12801
- Glens Falls Hospital
-
The Bronx, New York, Verenigde Staten, 10461
- Montefiore Medical Center-Einstein Campus
-
The Bronx, New York, Verenigde Staten, 10467
- Montefiore Medical Center - Moses Campus
-
The Bronx, New York, Verenigde Staten, 10461
- Montefiore Medical Center-Weiler Hospital
-
-
North Carolina
-
Kenansville, North Carolina, Verenigde Staten, 28349
- ECU Health Oncology Kenansville
-
Kinston, North Carolina, Verenigde Staten, 28501
- ECU Health Oncology Kinston
-
Pinehurst, North Carolina, Verenigde Staten, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Richlands, North Carolina, Verenigde Staten, 28574
- ECU Health Oncology Richlands
-
Washington, North Carolina, Verenigde Staten, 27889
- Marion L Shepard Cancer Center - ECU Health Beaufort Hospital
-
-
North Dakota
-
Fargo, North Dakota, Verenigde Staten, 58103
- Essentia Health Cancer Center-South University Clinic
-
Jamestown, North Dakota, Verenigde Staten, 58401
- Essentia Health - Jamestown Clinic
-
-
Ohio
-
Alliance, Ohio, Verenigde Staten, 44601
- Aultman Alliance Community Hospital
-
Beavercreek, Ohio, Verenigde Staten, 45431
- Indu and Raj Soin Medical Center
-
Boardman, Ohio, Verenigde Staten, 44512
- Saint Elizabeth Boardman Hospital
-
Canton, Ohio, Verenigde Staten, 44708
- Cleveland Clinic Mercy Hospital
-
Canton, Ohio, Verenigde Staten, 44710
- Aultman Health Foundation
-
Centerville, Ohio, Verenigde Staten, 45459
- Miami Valley Hospital South
-
Centerville, Ohio, Verenigde Staten, 45459
- Dayton Physicians LLC-Miami Valley South
-
Cincinnati, Ohio, Verenigde Staten, 45220
- Good Samaritan Hospital - Cincinnati
-
Cincinnati, Ohio, Verenigde Staten, 45242
- Bethesda North Hospital
-
Cincinnati, Ohio, Verenigde Staten, 45236
- Oncology Hematology Care Inc-Kenwood
-
Cincinnati, Ohio, Verenigde Staten, 45247
- TriHealth Cancer Institute-Westside
-
Cincinnati, Ohio, Verenigde Staten, 45255
- TriHealth Cancer Institute-Anderson
-
Cleveland, Ohio, Verenigde Staten, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, Verenigde Staten, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Dayton, Ohio, Verenigde Staten, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Verenigde Staten, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, Verenigde Staten, 45415
- Dayton Physician LLC - Englewood
-
Dayton, Ohio, Verenigde Staten, 45409
- Premier Blood and Cancer Center
-
Findlay, Ohio, Verenigde Staten, 45840
- Blanchard Valley Hospital
-
Findlay, Ohio, Verenigde Staten, 45840
- Armes Family Cancer Center
-
Findlay, Ohio, Verenigde Staten, 45840
- Orion Cancer Care
-
Franklin, Ohio, Verenigde Staten, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Franklin, Ohio, Verenigde Staten, 45005
- Dayton Physicians LLC-Atrium
-
Greenville, Ohio, Verenigde Staten, 45331
- Wayne Hospital
-
Greenville, Ohio, Verenigde Staten, 45331
- Dayton Physicians LLC-Wayne
-
Greenville, Ohio, Verenigde Staten, 45331
- Miami Valley Cancer Care and Infusion
-
Kettering, Ohio, Verenigde Staten, 45429
- Kettering Medical Center
-
Kettering, Ohio, Verenigde Staten, 45409
- Greater Dayton Cancer Center
-
Kettering, Ohio, Verenigde Staten, 45420
- First Dayton Cancer Care
-
Mansfield, Ohio, Verenigde Staten, 44906
- Cleveland Clinic Cancer Center Mansfield
-
Maumee, Ohio, Verenigde Staten, 43537
- Toledo Clinic Cancer Centers-Maumee
-
Mayfield Heights, Ohio, Verenigde Staten, 44124
- Hillcrest Hospital Cancer Center
-
Perrysburg, Ohio, Verenigde Staten, 43551
- Mercy Health - Perrysburg Hospital
-
Sandusky, Ohio, Verenigde Staten, 44870
- North Coast Cancer Care
-
Springfield, Ohio, Verenigde Staten, 45504
- Springfield Regional Cancer Center
-
Springfield, Ohio, Verenigde Staten, 45504
- Springfield Regional Medical Center
-
Strongsville, Ohio, Verenigde Staten, 44136
- Cleveland Clinic Cancer Center Strongsville
-
Toledo, Ohio, Verenigde Staten, 43623
- Mercy Health - Saint Anne Hospital
-
Toledo, Ohio, Verenigde Staten, 43623
- Toledo Clinic Cancer Centers-Toledo
-
Troy, Ohio, Verenigde Staten, 45373
- Upper Valley Medical Center
-
Troy, Ohio, Verenigde Staten, 45373
- Dayton Physicians LLC - Troy
-
Warren, Ohio, Verenigde Staten, 44484
- Saint Joseph Warren Hospital
-
Warrensville Heights, Ohio, Verenigde Staten, 44122
- South Pointe Hospital
-
Wooster, Ohio, Verenigde Staten, 44691
- Cleveland Clinic Wooster Family Health and Surgery Center
-
Wright-Patterson Air Force Base, Ohio, Verenigde Staten, 45433
- Wright-Patterson Medical Center
-
Youngstown, Ohio, Verenigde Staten, 44501
- Saint Elizabeth Youngstown Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Verenigde Staten, 73120
- Mercy Hospital Oklahoma City
-
-
Oregon
-
Baker City, Oregon, Verenigde Staten, 97814
- Saint Alphonsus Cancer Care Center-Baker City
-
Bend, Oregon, Verenigde Staten, 97701
- Saint Charles Health System
-
Clackamas, Oregon, Verenigde Staten, 97015
- Clackamas Radiation Oncology Center
-
Clackamas, Oregon, Verenigde Staten, 97015
- Providence Cancer Institute Clackamas Clinic
-
Coos Bay, Oregon, Verenigde Staten, 97420
- Bay Area Hospital
-
Newberg, Oregon, Verenigde Staten, 97132
- Providence Newberg Medical Center
-
Ontario, Oregon, Verenigde Staten, 97914
- Saint Alphonsus Cancer Care Center-Ontario
-
Oregon City, Oregon, Verenigde Staten, 97045
- Providence Willamette Falls Medical Center
-
Portland, Oregon, Verenigde Staten, 97239
- Oregon Health and Science University
-
Portland, Oregon, Verenigde Staten, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Verenigde Staten, 97225
- Providence Saint Vincent Medical Center
-
Redmond, Oregon, Verenigde Staten, 97756
- Saint Charles Health System-Redmond
-
-
Pennsylvania
-
Allentown, Pennsylvania, Verenigde Staten, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Allentown, Pennsylvania, Verenigde Staten, 18104
- Saint Luke's Cancer Center - Allentown
-
Bethlehem, Pennsylvania, Verenigde Staten, 18017
- Lehigh Valley Hospital - Muhlenberg
-
Bethlehem, Pennsylvania, Verenigde Staten, 18015
- Saint Luke's University Hospital-Bethlehem Campus
-
Bryn Mawr, Pennsylvania, Verenigde Staten, 19010
- Bryn Mawr Hospital
-
Chambersburg, Pennsylvania, Verenigde Staten, 17201
- Chambersburg Hospital
-
Chambersburg, Pennsylvania, Verenigde Staten, 17201
- WellSpan Medical Oncology and Hematology
-
Collegeville, Pennsylvania, Verenigde Staten, 19426
- Main Line Health Center-Collegeville
-
East Stroudsburg, Pennsylvania, Verenigde Staten, 18301
- Pocono Medical Center
-
Easton, Pennsylvania, Verenigde Staten, 18045
- Saint Luke's Hospital-Anderson Campus
-
Ephrata, Pennsylvania, Verenigde Staten, 17522
- Ephrata Cancer Center
-
Exton, Pennsylvania, Verenigde Staten, 19341
- Main Line Health Center-Exton
-
Gettysburg, Pennsylvania, Verenigde Staten, 17325
- Adams Cancer Center
-
Hanover, Pennsylvania, Verenigde Staten, 17331
- WellSpan Medical Oncology and Hematology
-
Hazleton, Pennsylvania, Verenigde Staten, 18201
- Lehigh Valley Hospital-Hazleton
-
Lebanon, Pennsylvania, Verenigde Staten, 17042
- Sechler Family Cancer Center
-
Media, Pennsylvania, Verenigde Staten, 19063
- Riddle Memorial Hospital
-
Newtown Square, Pennsylvania, Verenigde Staten, 19073
- Bryn Mawr Health Center
-
Paoli, Pennsylvania, Verenigde Staten, 19301
- Paoli Memorial Hospital
-
Philadelphia, Pennsylvania, Verenigde Staten, 19104
- University of Pennsylvania/Abramson Cancer Center
-
Philadelphia, Pennsylvania, Verenigde Staten, 19104
- Penn Presbyterian Medical Center
-
Pottstown, Pennsylvania, Verenigde Staten, 19464
- Pottstown Hospital
-
Quakertown, Pennsylvania, Verenigde Staten, 18951
- Saint Luke's Hospital-Quakertown Campus
-
Quakertown, Pennsylvania, Verenigde Staten, 18951
- Saint Luke's Hospital - Upper Bucks Campus
-
Sayre, Pennsylvania, Verenigde Staten, 18840
- Guthrie Medical Group PC-Robert Packer Hospital
-
Wynnewood, Pennsylvania, Verenigde Staten, 19096
- Lankenau Medical Center
-
York, Pennsylvania, Verenigde Staten, 17403
- WellSpan Health-York Cancer Center
-
York, Pennsylvania, Verenigde Staten, 17403
- WellSpan Health-York Hospital
-
York, Pennsylvania, Verenigde Staten, 17403
- Cancer Care Associates of York
-
-
South Carolina
-
Greenwood, South Carolina, Verenigde Staten, 29646
- Self Regional Healthcare
-
-
Texas
-
Bryan, Texas, Verenigde Staten, 77802
- Saint Joseph Regional Cancer Center
-
-
Virginia
-
Mechanicsville, Virginia, Verenigde Staten, 23116
- Bon Secours Memorial Regional Medical Center
-
Midlothian, Virginia, Verenigde Staten, 23114
- Bon Secours Saint Francis Medical Center
-
Midlothian, Virginia, Verenigde Staten, 23113
- Bon Secours Westchester Emergency Center
-
Norfolk, Virginia, Verenigde Staten, 23505
- Bon Secours DePaul Medical Center
-
Portsmouth, Virginia, Verenigde Staten, 23707
- Bon Secours Maryview Medical Center
-
Richmond, Virginia, Verenigde Staten, 23235
- VCU Massey Cancer Center at Stony Point
-
Richmond, Virginia, Verenigde Staten, 23226
- Bon Secours Saint Mary's Hospital
-
Richmond, Virginia, Verenigde Staten, 23230
- Bon Secours Cancer Institute at Reynolds Crossing
-
Richmond, Virginia, Verenigde Staten, 23223
- Bon Secours Richmond Community Hospital
-
Richmond, Virginia, Verenigde Staten, 23298
- VCU Massey Comprehensive Cancer Center
-
Suffolk, Virginia, Verenigde Staten, 23435
- Bon Secours Health Center at Harbour View
-
-
Washington
-
Aberdeen, Washington, Verenigde Staten, 98520
- Providence Regional Cancer System-Aberdeen
-
Bellevue, Washington, Verenigde Staten, 98004
- Overlake Medical Center
-
Bellingham, Washington, Verenigde Staten, 98225
- PeaceHealth Saint Joseph Medical Center
-
Burien, Washington, Verenigde Staten, 98166
- Saint Anne Hospital
-
Centralia, Washington, Verenigde Staten, 98531
- Providence Regional Cancer System-Centralia
-
Edmonds, Washington, Verenigde Staten, 98026
- Swedish Cancer Institute-Edmonds
-
Enumclaw, Washington, Verenigde Staten, 98022
- Saint Elizabeth Hospital
-
Everett, Washington, Verenigde Staten, 98201
- Providence Regional Cancer Partnership
-
Federal Way, Washington, Verenigde Staten, 98003
- Saint Francis Hospital
-
Issaquah, Washington, Verenigde Staten, 98029
- Swedish Cancer Institute-Issaquah
-
Kennewick, Washington, Verenigde Staten, 99336
- Kadlec Clinic Hematology and Oncology
-
Lacey, Washington, Verenigde Staten, 98503
- Providence Regional Cancer System-Lacey
-
Lakewood, Washington, Verenigde Staten, 98499
- Saint Clare Hospital
-
Longview, Washington, Verenigde Staten, 98632
- PeaceHealth Saint John Medical Center
-
Port Townsend, Washington, Verenigde Staten, 98368
- Jefferson Healthcare
-
Poulsbo, Washington, Verenigde Staten, 98370
- Harrison HealthPartners Hematology and Oncology-Poulsbo
-
Renton, Washington, Verenigde Staten, 98055
- Valley Medical Center
-
Seattle, Washington, Verenigde Staten, 98107
- Swedish Medical Center-Ballard Campus
-
Seattle, Washington, Verenigde Staten, 98122
- Swedish Medical Center-First Hill
-
Seattle, Washington, Verenigde Staten, 98104
- Pacific Gynecology Specialists
-
Seattle, Washington, Verenigde Staten, 98122-5711
- Swedish Medical Center-Cherry Hill
-
Sedro-Woolley, Washington, Verenigde Staten, 98284
- PeaceHealth United General Medical Center
-
Shelton, Washington, Verenigde Staten, 98584
- Providence Regional Cancer System-Shelton
-
Silverdale, Washington, Verenigde Staten, 98383
- Saint Joseph Medical Center Hematology and Oncology - Silverdale
-
Tacoma, Washington, Verenigde Staten, 98405
- Northwest Medical Specialties PLLC
-
Tacoma, Washington, Verenigde Staten, 98405
- Franciscan Research Center-Northwest Medical Plaza
-
Vancouver, Washington, Verenigde Staten, 98664
- PeaceHealth Southwest Medical Center
-
Walla Walla, Washington, Verenigde Staten, 99362
- Providence Saint Mary Regional Cancer Center
-
Yakima, Washington, Verenigde Staten, 98902
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
-
Yelm, Washington, Verenigde Staten, 98597
- Providence Regional Cancer System-Yelm
-
-
West Virginia
-
Huntington, West Virginia, Verenigde Staten, 25701
- Edwards Comprehensive Cancer Center
-
-
Wisconsin
-
Appleton, Wisconsin, Verenigde Staten, 54911
- ThedaCare Regional Cancer Center
-
Ashland, Wisconsin, Verenigde Staten, 54806
- Duluth Clinic Ashland
-
Ashland, Wisconsin, Verenigde Staten, 54806
- Northwest Wisconsin Cancer Center
-
Berlin, Wisconsin, Verenigde Staten, 54923
- ThedaCare Cancer Care - Berlin
-
Burlington, Wisconsin, Verenigde Staten, 53105
- Aurora Cancer Care-Southern Lakes VLCC
-
Chippewa Falls, Wisconsin, Verenigde Staten, 54729
- Marshfield Clinic-Chippewa Center
-
Cudahy, Wisconsin, Verenigde Staten, 53110
- Aurora Saint Luke's South Shore
-
Eau Claire, Wisconsin, Verenigde Staten, 54701
- Marshfield Medical Center-EC Cancer Center
-
Germantown, Wisconsin, Verenigde Staten, 53022
- Aurora Health Care Germantown Health Center
-
Grafton, Wisconsin, Verenigde Staten, 53024
- Aurora Cancer Care-Grafton
-
Green Bay, Wisconsin, Verenigde Staten, 54311
- Aurora BayCare Medical Center
-
Hayward, Wisconsin, Verenigde Staten, 54843
- Essentia Health-Hayward Clinic
-
Kenosha, Wisconsin, Verenigde Staten, 53142
- Aurora Cancer Care-Kenosha South
-
La Crosse, Wisconsin, Verenigde Staten, 54601
- Gundersen Lutheran Medical Center
-
Ladysmith, Wisconsin, Verenigde Staten, 54848
- Marshfield Medical Center - Ladysmith
-
Marinette, Wisconsin, Verenigde Staten, 54143
- Aurora Bay Area Medical Group-Marinette
-
Marshfield, Wisconsin, Verenigde Staten, 54449
- Marshfield Medical Center-Marshfield
-
Milwaukee, Wisconsin, Verenigde Staten, 53209
- Aurora Cancer Care-Milwaukee
-
Milwaukee, Wisconsin, Verenigde Staten, 53215
- Aurora Saint Luke's Medical Center
-
Milwaukee, Wisconsin, Verenigde Staten, 53233
- Aurora Sinai Medical Center
-
Minocqua, Wisconsin, Verenigde Staten, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, Verenigde Staten, 53149
- ProHealth D N Greenwald Center
-
New Richmond, Wisconsin, Verenigde Staten, 54017
- Cancer Center of Western Wisconsin
-
Oconomowoc, Wisconsin, Verenigde Staten, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Oshkosh, Wisconsin, Verenigde Staten, 54904
- Vince Lombardi Cancer Clinic - Oshkosh
-
Racine, Wisconsin, Verenigde Staten, 53406
- Aurora Cancer Care-Racine
-
Rice Lake, Wisconsin, Verenigde Staten, 54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan, Wisconsin, Verenigde Staten, 53081
- Vince Lombardi Cancer Clinic-Sheboygan
-
Spooner, Wisconsin, Verenigde Staten, 54801
- Essentia Health-Spooner Clinic
-
Stevens Point, Wisconsin, Verenigde Staten, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Summit, Wisconsin, Verenigde Staten, 53066
- Aurora Medical Center in Summit
-
Superior, Wisconsin, Verenigde Staten, 54880
- Essentia Health Saint Mary's Hospital - Superior
-
Two Rivers, Wisconsin, Verenigde Staten, 54241
- Vince Lombardi Cancer Clinic-Two Rivers
-
Waukesha, Wisconsin, Verenigde Staten, 53188
- UW Cancer Center at ProHealth Care
-
Waukesha, Wisconsin, Verenigde Staten, 53188
- ProHealth Waukesha Memorial Hospital
-
Wausau, Wisconsin, Verenigde Staten, 54401
- Marshfield Clinic-Wausau Center
-
Wauwatosa, Wisconsin, Verenigde Staten, 53226
- Aurora Cancer Care-Milwaukee West
-
Weston, Wisconsin, Verenigde Staten, 54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids, Wisconsin, Verenigde Staten, 54494
- Marshfield Clinic - Wisconsin Rapids Center
-
-
Wyoming
-
Cheyenne, Wyoming, Verenigde Staten, 82001
- Cheyenne Regional Medical Center-West
-
Cody, Wyoming, Verenigde Staten, 82414
- Billings Clinic-Cody
-
Sheridan, Wyoming, Verenigde Staten, 82801
- Welch Cancer Center
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
-
RANDOMIZATION (STEP 1): Patient must be >= 18 years of age
-
RANDOMIZATION (STEP 1): Patient must have pathologically confirmed non-squamous non-small cell lung carcinoma (NSCLC). Patients with NSCLC not otherwise specified (NOS) are eligible. Mixed tumors will be categorized by predominant cell type. If small cell elements are present, the patient is ineligible
-
RANDOMIZATION (STEP 1): Patient must have metastatic stage IVA or IVB disease (includes M1a, M1b, and M1c), according to the 8th edition of the lung cancer TNM classification system. Recurrent metastatic NSCLC ineligible for curative therapy (in the treating investigator's opinion) is also allowed
-
RANDOMIZATION (STEP 1): Patient's tumor must be known negative for EGFR tyrosine kinase inhibitor (TKI) sensitizing mutations (for example at a minimum, negative for EGFR Exon 19 deletions, EGFR exon 20 insertions, and Exon 21 L858R, L861Q mutations ) AND negative for ALK gene rearrangements (by fluorescence in situ hybridization [FISH], next generation sequencing [NGS], or immunohistochemistry [IHC]) by routine Clinical Laboratory Improvement Amendments (CLIA)- or Food and Drug Administration (FDA)-certified clinical testing methods. CLIA or FDA approved circulating tumor deoxyribonucleic acid (DNA) testing is acceptable as an alternative to tissue testing
-
RANDOMIZATION (STEP 1): Patient must have radiographic and/or clinical progression (per local investigator assessment) following one, but only one, line of platinum-based chemotherapy AND one, but only one, line of prior checkpoint inhibitor (anti-PD-1 or PD-L1) immunotherapy, either concurrently or sequentially in either order. A minimum of two doses of prior immunotherapy is required. Only one prior line of therapy is allowed if patients received chemotherapy and immunotherapy together (patients may not receive subsequent single agent chemotherapy), and greater than two prior lines of therapy are not allowed.
- NOTE: Lines of therapy are defined by clinical or radiographic progression. For patients with recurrent metastatic NSCLC following treatment for stage 1-3 NSCLC, platinum-based chemotherapy received within 12 months of recurrence and/or immunotherapy received within 6 months of recurrence will meet the requirement for prior chemotherapy and/or immunotherapy but subsequent receipt of more immunotherapy and/or platinum-based chemotherapy is also allowed.
- NOTE: Prior anti-VEGF antibody therapy (ie bevacizumab) is allowed. Prior ipilimumab, or investigational agents not excluded below, in combination with the required prior therapies above are allowed.
- NOTE: Prior receipt of one or two lines of targeted therapy for ROS1, RET, MET, BRAF, ERBB2/HER2, or KRAS G12C positive NSCLC is allowed and will not count toward the line of therapy limit. However, progression is still required after chemotherapy and immunotherapy as above. Patients with ROS1, RET, MET positive NSCLC are strongly encouraged to get appropriate targeted therapy (such as crizotinib, entrectinib, lorlatinib, selpercatinib, pralsetinib, capmatinib, tepotinib, or another investigational, off-label, or approved agent directed against ROS1, RET, or MET positive NSCLC) prior to participation and will be stratified.
- NOTE: No prior predominantly VEGFR directed TKI therapy (such as cabozantinib, lenvatinib, or sitravantinib) is allowed, except for the agents named above.
-
RANDOMIZATION (STEP 1): The investigator must document the intended chemotherapy regimen should their patient be randomized to Arm C (docetaxel and ramucirumab, OR single agent chemotherapy - docetaxel, gemcitabine, paclitaxel, nab-paclitaxel). The patient must not have received the selected chemotherapy agent previously for metastatic disease
-
RANDOMIZATION (STEP 1): Any prior chemotherapy (based on administration schedule) must have been completed in greater than or equal to the following times prior to randomization:
- FDA approved targeted oral therapy must be completed >= 1 week prior
- Chemotherapy and/or immunotherapy must be completed >= 2 weeks prior
- Prior investigational agents must be completed >= 4 weeks prior.
-
RANDOMIZATION (STEP 1): Prior radiation therapy is allowed with a 2 week washout prior to randomization. Patient must not receive any systemic treatment with radionuclides within 6 weeks prior to randomization. Patient must have no clinically relevant ongoing complication from prior radiation therapy
-
RANDOMIZATION (STEP 1): Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen (in the opinion of the treating physician) are eligible for this trial
-
RANDOMIZATION (STEP 1): Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents (such as anthracycline or HER2-directed antibody therapy, but not prior checkpoint inhibitor therapy), must have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients must be class 2B or better
-
RANDOMIZATION (STEP 1): Patient must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must have met the eligibility criteria outlined above
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must have measurable disease as defined by RECIST v1.1. Measurements must be obtained within 4 weeks prior to randomization/registration
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must have recovered to equal to or less than grade 1 toxicities related to prior treatment, unless toxicities are clinically non significant and/or stable on supportive therapy (as determined by the treating physician)
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Absolute neutrophil count >= 1,500/mcL (obtained within 2 weeks prior to randomization)
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Platelets >= 100,000/mcL (obtained within 2 weeks prior to randomization)
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Hemoglobin >= 9 g/dL (obtained within 2 weeks prior to randomization)
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (for patients with Gilbert's disease total bilirubin must be =< 3 x ULN) (obtained within 2 weeks prior to randomization)
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Aspartate aminotransferase (AST)(serum glutamic oxaloacetic transaminase [SGOT]) and alanine aminotransferase (ALT)(serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x ULN (obtained within 2 weeks prior to randomization)
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Creatinine =< 1.5 x ULN OR calculated (Cockcroft-Gault formula) or measured creatinine clearance >= 50 mL/min/1.73m^2 (normalized to body surface area [BSA]) for patients with creatinine levels greater than 1.5 times the institutional normal creatinine =< 1.5 X ULN or creatinine clearance >= 50ml/min/1.73m^2 (obtained within 2 weeks prior to randomization)
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not be pregnant or breast-feeding due to the unknown effects of cabozantinib and nivolumab on human development and for the potential risk for adverse events in nursing infants with the treatment regimens being used.
- All patients of childbearing potential must have a blood test or urine study within 14 days prior to randomization/registration to rule out pregnancy.
- A patient of childbearing potential is anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months).
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse for the duration of their participation in the study and for 6 months after completion of treatment on the study
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have clinically significant gastrointestinal bleeding within 6 months prior to randomization
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have pulmonary hemorrhage or hemoptysis of >= 0.5 teaspoon (2.5 mL) of red blood within 3 months prior to randomization
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have active drug induced pneumonitis within 3 months prior to randomization. Prior immune mediated pneumonitis of grade 3 or 4 are not eligible regardless of time window
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have current radiographic evidence of tumor invading major blood vessel, evidence of tumor cavitation > 1 cm, evidence of tumor invading the gastrointestinal (GI) tract (esophagus, stomach, small or large bowel, rectum or anus), or evidence of endotracheal or mainstem endobronchial tumor
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have peptic ulcer disease, known malabsorption syndrome, bowel obstruction or gastric outlet obstruction within 3 months prior to randomization
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have abdominal fistula, GI perforation, or intra-abdominal abscess within 6 months prior to randomization
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have grade 3 or greater infection, or infection requiring intravenous systemic treatment within 14 days prior to randomization. Patients must be off antibiotics at the time of randomization
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have serious non-healing wound/ulcer/bone fracture within 28 days prior to randomization
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have history of organ transplant
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have concurrent symptomatic untreated hypothyroidism
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have history of major surgery within 3 months prior to randomization, minor surgery within 28 days prior to randomization, other minor procedures within 7 days prior to randomization, or clinically relevant ongoing complications from prior procedures
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have concurrent uncontrolled hypertension defined as sustained blood pressure (BP) > 160 mm Hg systolic, or > 100 mm Hg diastolic despite optimal antihypertensive treatment
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have unstable angina pectoris, clinically-significant cardiac arrhythmias, stroke (including transient ischemic attack [TIA]), or myocardial infarction within 6 months prior to randomization
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have a diagnosis of deep vein thrombosis/pulmonary embolism (DVT/PE) within 6 months of randomization unless stable, asymptomatic, and treated with low-molecular-weight heparin (LMWH) or a permitted oral anticoagulant for at least 7 days before randomization
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not be receiving anticoagulants (i.e., warfarin, aspirin, clopidogrel) except:
- Prophylactic use of low-dose aspirin (100 mg po daily or less) and/or low dose molecular weight heparin (LMWH) is permitted.
- Therapeutic doses of low dose molecular weight heparin (LMWH) or specified direct factor Xa inhibitors rivaroxaban, edoxaban, or apixaban are allowed in patients without untreated brain metastases who are on a stable dose 7 days prior to study randomization, and without clinically significant hemorrhagic complications from the anticoagulation regimen or the tumor
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not receive strong CYP3A4 inducers (e.g., dexamethasone (> 1 mg daily dosing), phenytoin, carbamazepine, rifampin, rifabutin, rifapentine, phenobarbital, and St. John's Wort) within 7 days prior to randomization
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must have corrected QT interval calculated by the Fridericia formula (QTcF) =< 500 msec within 28 days prior to Step 1 randomization
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must be able to swallow tablets
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not be on continuous systemic treatment with corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 7 days prior to randomization, with the following exceptions:
- Inhaled or topical steroids and adrenal replacement doses =< 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease.
- Patients are permitted to use topical, ocular, intra-articular, intranasal, and inhalational corticosteroids (with minimal systemic absorption).
- Physiologic replacement doses of systemic corticosteroids are permitted, if < 10 mg/day prednisone equivalents. A brief course of corticosteroids for prophylaxis (e.g., contrast dye allergy) or for treatment of non-autoimmune conditions (e.g., delayed-type hypersensitivity reaction caused by contact allergen) is permitted
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients with brain metastases are eligible as follows:
- Previously treated brain metastases must have been treated with radiation > 2 weeks prior to randomization or surgery > 3 months prior to randomization OR
- Untreated (active) brain metastases are allowed if they are clinically asymptomatic, < 1 cm, non-hemorrhagic, the patient is not on systemic anticoagulation, and the investigator believes that central nervous system (CNS) specific treatment is unlikely to be required during the first 3 months of study treatment.
- NOTE: Symptomatic leptomeningeal disease is NOT allowed
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not have known active autoimmune disease or known history of autoimmune disease for which recurrence may affect vital organ function or require immune suppressive treatment including systemic corticosteroids (e.g., immune-related neurologic disease, multiple sclerosis, autoimmune neuropathy, Guillain-Barre syndrome, etc.).
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients with known history of human immunodeficiency virus (HIV)-infection must be on effective anti-retroviral therapy with undetectable viral load within 6 months of randomization
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients with known history of chronic hepatitis B virus (HBV) infection must have undetectable HBV viral at time of randomization (suppressive therapy is allowed, if indicated)
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients with a known history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load at time of randomization
-
RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not have had any prior allergic reaction or hypersensitivity to study drug components or related drugs (multitargeted small molecule tyrosine kinase inhibitors or checkpoint inhibitor monoclonal antibodies)
-
STEP 2 (CROSSOVER ARM Z): Patient must have met all eligibility requirements for Step 1 at time of registration to Step 1 to be eligible for Step 2
-
STEP 2 (CROSSOVER ARM Z): Patient must have radiographic progressive disease per RECIST criteria after >= 2 cycles of therapy on Arm C. The scan showing progression must be completed within 6 weeks prior to Step 2 registration
-
STEP 2 (CROSSOVER ARM Z): Patient must not have intervening anticancer treatment or major surgical procedure(s) between Step 1 and Step 2, except palliative radiation which was completed >= 1 week prior to registration to Step 2
-
STEP 2 (CROSSOVER ARM Z): Patient may not have central nervous system progression, but patients with stable CNS disease are allowed
-
STEP 2 (CROSSOVER ARM Z): Patient must have an ECOG performance status 0-2
-
STEP 2 (CROSSOVER ARM Z): Patient must have recovered to equal to or less than grade 1 toxicities related to prior treatment, unless the adverse event(s) are clinically non significant and/or stable on supportive therapy (as determined by the treating physician)
-
STEP 2 (CROSSOVER ARM Z): Absolute neutrophil count >= 1,500/mcL (obtained within 2 weeks prior to registration to Step 2)
-
STEP 2 (CROSSOVER ARM Z): Platelets >= 100,000/mcL (obtained within 2 weeks prior to registration to Step 2)
-
STEP 2 (CROSSOVER ARM Z): Hemoglobin >= 9 g/dL (obtained within 2 weeks prior to registration to Step 2)
-
STEP 2 (CROSSOVER ARM Z): Total bilirubin =< 1.5 x institutional ULN (for patients with Gilbert's disease total bilirubin must be =< 3 x ULN) (obtained within 2 weeks prior to registration to Step 2)
-
STEP 2 (CROSSOVER ARM Z): AST(SGOT) and ALT(SGPT) =< 2.5 x ULN (obtained within 2 weeks prior to registration to Step 2)
-
STEP 2 (CROSSOVER ARM Z): Creatinine =< 1.5 x ULN OR calculated (Cockcroft-Gault formula) or measured creatinine clearance >= 50 mL/min/1.73m^2 (normalized to BSA) for patients with creatinine levels greater than 1.5 times the institutional normal creatinine =< 1.5 X ULN or creatinine clearance >= 50ml/min/1.73m^2 (obtained within 2 weeks prior to registration to Step 2)
-
STEP 2 (CROSSOVER ARM Z): Patient must have corrected QT interval calculated by the Fridericia formula (QTcF) =< 500 ms within 28 days prior to Step 2 registration
-
STEP 2 (CROSSOVER ARM Z): Patient must not have any intercurrent illness or disease complication that the investigator believes would limit the ability to safely tolerate the combination of cabozantinib and nivolumab
-
STEP 2 (CROSSOVER ARM Z): Patient must not be pregnant or breast-feeding due to the unknown effects of cabozantinib and nivolumab on human development and for the potential risk for adverse events in nursing infants with the treatment regimens being used.
- All patients of childbearing potential must have a blood test or urine study within 14 days prior to registration to Step 2 to rule out pregnancy.
- A patient of childbearing potential is anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months).
-
STEP 2 (CROSSOVER ARM Z): Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse for the duration of their participation in the study and for 6 months after completion of treatment on the study
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Step 1, Arm A (cabozantinib S-malate)
Patients in Step 1, Arm A receive cabozantinib S-malate PO QD. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit. Patients also undergo ECHO as clinically indicated, CT throughout the trial, and collection of blood on study. |
Undergo CT
Andere namen:
Given PO
Andere namen:
Undergo ECHO
Andere namen:
Undergo blood collection
Andere namen:
|
|
Experimenteel: Step 1, Arm B (cabozantinib S-malate, nivolumab)
Patients in Step 1, Arm B receive cabozantinib S-malate PO QD and nivolumab IV over 30 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit. Patients also undergo ECHO as clinically indicated, CT throughout the trial, and collection of blood on study. |
Undergo CT
Andere namen:
Given PO
Andere namen:
Undergo ECHO
Andere namen:
Given IV
Andere namen:
Undergo blood collection
Andere namen:
|
|
Actieve vergelijker: Step 1, Arm C (standard chemotherapy)
Patients in Step 1, Arm C receive ramucirumab IV over 30-60 minutes and docetaxel IV over 1 hour on day 1, or docetaxel IV over 1 hour on days 1 and 8, or gemcitabine hydrochloride IV on days 1 and 8, or paclitaxel IV over 3 hours on day 1, or nab-paclitaxel IV over 30 minutes on days 1 and 8. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity and at the discretion of the treating physician. Patients also undergo ECHO as clinically indicated, CT throughout the trial, and collection of blood on study. |
Given IV
Andere namen:
Given IV
Andere namen:
Undergo CT
Andere namen:
Undergo ECHO
Andere namen:
Undergo blood collection
Andere namen:
Given IV
Andere namen:
Given PO
Andere namen:
Given IV
Andere namen:
|
|
Experimenteel: Step 2, Arm Z (cabozantinib S-malate, nivolumab)
Patients in Step 2, Arm Z receive cabozantinib S-malate PO QD and nivolumab IV over 30 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit. Patients also undergo ECHO as clinically indicated, CT throughout the trial, and collection of blood on study. |
Undergo CT
Andere namen:
Given PO
Andere namen:
Undergo ECHO
Andere namen:
Given IV
Andere namen:
Undergo blood collection
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Progression-free survival (PFS) for patient population with non-squamous no-small cell lung cancer (NSCLC)
Tijdsspanne: After 58 events (From time of randomization to documented disease progression [site review of imaging] or death from any cause, whichever occurs first)
|
The final analysis of PFS will be performed when the full information of PFS is reached (i.e., 58 events for each of the two primary comparisons). The two primary comparisons of PFS will each use a logrank test stratified on the randomization stratification factors with a one-sided type I error rate of 10%. Estimates of PFS including medians and confidence intervals, will be calculated using the Kaplan-Meier method. Cox proportional hazards models, stratified, on the same factors, will be used to estimate the treatment hazard ratios. At the final analyses, in the event that both primary PFS comparisons of the combination of nivolumab with cabozantinib and cabozantinib alone versus the standard chemotherapy are statistically significant, PFS will be compared between the two experimental arms (combination of nivolumab with cabozantinib versus [vs.] cabozantinib alone), using a stratified log rank test with a one-sided type I error rate of 10%. |
After 58 events (From time of randomization to documented disease progression [site review of imaging] or death from any cause, whichever occurs first)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Overall survival (OS) for each arm
Tijdsspanne: From time of randomization to documented disease progression (site review of imaging) or death from any cause, whichever occurs first, assessed up to 3 years
|
The final analysis of OS will be performed when the full information of PFS is reached (i.e., 58 events for each of the two primary comparisons). OS will be tested in a hierarchical fashion if the primary comparison of PFS between treatment arms is statistically significant, using a log rank test stratified on the randomization stratification factors with a one-sided type I error rate of 10%. Estimates of OS, including medians and confidence intervals, will be calculated using the Kaplan-Meier method. Cox proportional hazards models, stratified, on the same factors, will be used to estimate the treatment hazard ratios. OS will be further tested in a hierarchical fashion if the comparison of PFS between the two experimental arms is statistically significant. Point estimates of all endpoints will be accompanied by the corresponding two-sided 80% confidence intervals. Subset analyses of PFS and OS by treatment arm will be estimated and compared within subsets. |
From time of randomization to documented disease progression (site review of imaging) or death from any cause, whichever occurs first, assessed up to 3 years
|
|
Best objective response for each arm
Tijdsspanne: Every 6 weeks for the first year on study, and then every 12 weeks after year one
|
Will be evaluated via Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria. Response rates (complete response [CR] + partial response [PR]) and toxicity will be compared using Fisher's exact tests with a one-sided type I error rate of 10%; multivariable logistic regression modeling will be used to adjust for the effect of any covariates that are associated with these categorical outcomes. Modeling procedures will implement backward selection; variables significant at the 0.10 level in the univariate setting will be chosen for inclusion in an initial full model, and at each step the least significant variable will be removed from the model. Only those covariates with p < 0.05 will remain in any final models, unless there are factors identified by the study team as crucial to model interpretation. Point estimates of all endpoints will be accompanied by the corresponding two-sided 80% confidence intervals. |
Every 6 weeks for the first year on study, and then every 12 weeks after year one
|
|
Toxicity profile of monotherapy with cabozantinib, and the combination of nivolumab and cabozantinib
Tijdsspanne: Up to 3 years after completion of study treatment
|
Will be determined using the Common Terminology Criteria for Adverse Events (CTCAE) criteria. Response rates (complete response [CR] + pathologic response [PR]) and toxicity will be compared using Fisher's exact tests with a one-sided type I error rate of 10%; multivariable logistic regression modeling will be used to adjust for the effect of any covariates that are associated with these categorical outcomes. Modeling procedures will implement backward selection; variables significant at the 0.10 level in the univariate setting will be chosen for inclusion in an initial full model, and at each step the least significant variable will be removed from the model. Only those covariates with p < 0.05 will remain in any final models, unless there are factors identified by the study team as crucial to model interpretation. Point estimates of all endpoints will be accompanied by the corresponding two-sided 80% confidence intervals. |
Up to 3 years after completion of study treatment
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
The RECIST1.1 response at each time point
Tijdsspanne: Every 6 weeks for the first year on study, and then every 12 weeks after year one
|
The measurement of each time point will be performed using the revised CHOI criteria will be only applied to arms A and B, which will include anti-angiogenic therapy. Both the RECIST1.1 and revised CHOI criteria will assess the overall best response as CR, partial PR, stable disease (SD), or progressive disease (PD). Their concordance will be assessed using the weighted Cohen's kappa coefficient (k) with quadratic weights. As a rule of thumb, the level of concordance between the two criteria will be considered poor (k <0), slight (k 0-0.20), fair (k 0.21-0.40), moderate (k 0.41-0.60), substantial (k 0.61-0.80), and almost perfect (k 0.81 - 1). |
Every 6 weeks for the first year on study, and then every 12 weeks after year one
|
|
Agreement between central view and site review in terms of progression-free survival
Tijdsspanne: After the completion of study treatment
|
The progression status and the progression time will be assessed in agreement. The progression status is a binary measurement and the agreement will be assessed using the Cohen's kappa coefficient. For progression time, will assess the temporal agreement using the method developed by Zeng et al. |
After the completion of study treatment
|
|
Correlative biomarker research
Tijdsspanne: After the completion of study treatment
|
Correlative biomarker research will be performed on tissue and blood specimens collected within this trial. |
After the completion of study treatment
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Joel W Neal, ECOG-ACRIN Cancer Research Group
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Neoplasmata per site
- Neoplasmata
- Ziekten van de luchtwegen
- Longziekten
- Neoplasmata van de luchtwegen
- Thoracale neoplasmata
- Longneoplasmata
- Aminozuren, peptiden en eiwitten
- Eiwitten
- Organische chemicaliën
- Heterocyclische verbindingen, 1-ring
- Heterocyclische verbindingen
- Onderzoekstechnieken
- Klinische laboratoriumtechnieken
- Diagnostische technieken en procedures
- Diagnose
- Koolwaterstoffen
- Cycloparaffins
- Koolwaterstoffen, alicyclisch
- Koolwaterstoffen, cyclisch
- Terpenen
- Antilichamen, monoklonaal, gehumaniseerd
- Antilichamen, monoklonaal
- Antilichamen
- Immunoglobulinen
- Immunoproteïnen
- Bloedeiwitten
- Serum -globulines
- Globulines
- Taxoids
- Cyclodecanes
- Diterpenen
- Deoxycytidine
- Cytidine
- Pyrimidine -nucleosiden
- Pyrimidines
- Gezondheidszorg economie en organisaties
- Albumins
- Economie
- Docetaxel
- Nivolumab
- Albumine-gebonden paclitaxel
- Gemcitabine
- Ramucirumab
- Paclitaxel
- Exemplaarbehandeling
- 130-nm albumine-gebonden Paclitaxel
- cabozantinib
- Belastingen
Andere studie-ID-nummers
- NCI-2020-01541
- U10CA180820 (Subsidie/contract van de Amerikaanse NIH)
- NCI-2020-01541 (Register-ID: CTRP (Clinical Trial Reporting Program))
- EA5191 (Andere identificatie: CTEP)
- EA5191 (Andere identificatie: ECOG-ACRIN Cancer Research Group)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .